TGA-Registered Sublingual Immunotherapy Product
Oralair is a TGA-registered sublingual immunotherapy (SLIT) product developed in Europe for the treatment of temperate grass pollen allergy, including rye grass — the most common pollen allergen in Australia. It provides a needle-free treatment option that can be administered at home after the first supervised dose in clinic.
Overview
Oralair is designed as a five-grass mix, offering comprehensive coverage for patients sensitised to multiple temperate grasses.
Its TGA registration assures compliance with Australian safety and quality standards.
Safety Profile
Oralair has a well-established safety profile. Most side effects are local and mild, including:
Common side effects include:
Oral or throat itching or discomfort
Mild swelling under the tongue
Temporary irritation or tingling sensations
Effectiveness
Clinical studies demonstrate that Oralair effectively reduces grass pollen allergy symptoms and decreases medication use over a 3–5 year treatment course.
Daily adherence is critical, and benefits usually become apparent over several months of consistent use.
3–5 year treatment course
Treatment options
Single allergen therapy
Single allergen therapy:
Not applicable; Oralair is fixed as a five-grass mix.
Multi-allergen therapy
Multi-allergen therapy:
Provided inherently through the five-grass composition, covering key temperate grasses including rye grass.
Both TGA-registered and non-registered options exist.
Clinics must inform patients that all options are privately funded in Australia, with total treatment costs varying from several hundred to several thousand dollars per year.
First dose administered under clinic supervision
Subsequent daily doses taken at home under the tongue
Consistent daily dosing is critical for effectiveness
Contact the clinic if any severe reactions occur
Patient Suitability
Oralair may be appropriate for patients who:
Have confirmed IgE-mediated temperate grass pollen allergy
Are looking for a needle-free home-based option
Can commit to daily adherence over the treatment period
Are seeking a TGA-registered treatment option with proven efficacy for rye grass and related grasses
Australian Context
Not PBS-subsidised; treatment is privately funded
Conclusion
Oralair provides a safe, effective, and convenient SLIT option for patients allergic to temperate grasses, including rye grass.
Its five-grass mix delivers comprehensive coverage for common Australian allergens, with the convenience of home-based daily dosing.
Specialist supervision ensures safety and supports optimal treatment outcomes.
